Kensington is excited to announce the addition of Jeremy Freedman to our Advisory Board. Jeremy embarked on his professional journey as a trial lawyer with Davies, Ward & Beck (now “Davies”) in 1986. In 2000, he transitioned into the financial sector, joining Gluskin Sheff + Associates, Inc., a distinguished small-cap equity investment firm, where he served as vice president. In this capacity, he played a pivotal role in shaping business strategy and fostering client development.
Jeremy was appointed Chief Operating Officer in 2001, overseeing the firm’s day-to-day operations. In 2010, he assumed the role of President & CEO, guiding Gluskin Sheff + Associates through 15 years of transformative growth. Under his leadership, the firm expanded its investment portfolio, incorporating hedge funds, fixed-income securities, and various equity offerings. Assets under management grew impressively from $670 million to $8.5 billion.
Jeremy’s educational background includes a Juris Doctor degree from Queen’s University, where he served as the elected Rector from 1980-1982 and was called to the Bar of Ontario in 1984. Further enriching his legal foundation, he earned an MBA from the renowned Harvard Business School in 1986, graduating as a Baker Scholar.
Beyond his professional achievements, Jeremy is a devoted philanthropist, actively participating on several charitable boards, including the Diabetes Hope Foundation, the Simon Wiesenthal Center for Holocaust Studies, the North York General Hospital Foundation, and the Ronnen Harary Foundation. Additionally, he co-chairs the Endowment Fundraising Campaign for Maccabi Canada, reflecting his dedication to community welfare.
